R44DA046151
Project Grant
Overview
Grant Description
Rae (Realize, Analyze, Engage) - a digital biomarker based detection and intervention system for stress and craving during recovery from substance abuse disorders.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Worcester,
Massachusetts
01655
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/21 to 03/31/24 and the total obligations have increased 683% from $224,991 to $1,761,150.
Continue You was awarded
Project Grant R44DA046151
worth $1,761,150
from National Institute on Drug Abuse in June 2019 with work to be completed primarily in Worcester Massachusetts United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.
The Project Grant was awarded through grant opportunity Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44).
SBIR Details
Research Type
SBIR Phase II
Title
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
Abstract
PROJECT SUMMARY The research project outlined in this SBIR submission will develop the Realize, Analyze, Engage (RAE) platform into a tool to promote sustained recovery in individuals receiving treatment for substance use disorder. In this proposal, the investigators intend to deploy the RAE system- consisting of a wearable sensor, a smartphone app, and a clinical portal- to provide individuals in recovery and their treatment providers with an opportunity to identify moments of high risk for relapse and to access real time intervention opportunities. Wearable biosensors are small, noninvasive devices that continuously record physiology. These sensors have the ability to detect digital biomarkers of drug use and stress, the latter of which herald an increased risk of relapse. RAE aims to utilize this capability to create a real-time solution for individuals in recovery. The components of RAE are: 1) The Empatica Embrace, a wrist mounted sensor similar in form factor to a smart watch, that continuously monitors skin temperature, electrodermal activity (EDA) and locomotion. Detection algorithms for stress and drug use will be embedded on the Embrace firmware. 2) The RAE smartphone application (app), for the individual in recovery. The app will be triggered either by detection of an event on the Embrace or manually by the user when needed and will provide multiple options for annotations, stress reduction techniques and immediate contact with individuals in the pre-defined support system via call or SMS text. The app will also log sleep, physical activity, and geographic location of events. 3) The RAE Portal, for the treatment provider, will deliver immediate alerts when an event is detected on the user’s device for the opportunity to intervene in real time and will also provide metrics on the user’s recorded activities. The research plan has two Specific Aims: Aim 1) To deploy and optimize the RAE system in a population of individuals in treatment for substance use disorder and Aim 2) To demonstrate the impact of the RAE system on outcomes in substance use treatment. To achieve these aims the investigators will first deploy the technology in a population of individuals in recovery and collect data on accuracy, usability and functionality (Aim 1). The data from Aim 1 will be used to optimize the system and achieve millstones prior to transition to Aim 2 which will include sensitivity, specify, accuracy and user compliance targets. The investigators will then undertake a multi-site, randomized controlled trial (Aim 2) to evaluate the efficacy of RAE on key outcomes including rates of relapse, retention in treatment programs, and psychosocial wellbeing. The investigators have assembled a leadership team and advisory team with the necessary expertise in business, medicine, wearable technology and engineering to develop RAE into a tool that dramatically improves the success of treatment for substance use disorder, promotes sustained sobriety, and reduces morbidity and mortality from relapse to substance use.PROJECT NARRATIVE Morbidity and mortality related to substance use disorder has reached staggering proportions, and treatment options suffer from high rates of relapse. RAE (Realize, Analyze, Engage) is a mobile based solution that combines a wearable sensor, a smartphone app and a cloud based clinical portal to detect stress and drug use in individuals in treatment for substance use disorder. The goal of the RAE system is to provide real-time intervention tools for patients, to allow clinicians to personalize the treatment approach for each patient, and ultimately to reduce morbidity and mortality from substance use disorder by improving the success of treatment programs.
Topic Code
NIDA
Solicitation Number
DA18-010
Status
(Complete)
Last Modified 8/5/24
Period of Performance
6/15/19
Start Date
3/31/24
End Date
Funding Split
$1.8M
Federal Obligation
$0.0
Non-Federal Obligation
$1.8M
Total Obligated
Activity Timeline
Transaction History
Modifications to R44DA046151
Additional Detail
Award ID FAIN
R44DA046151
SAI Number
R44DA046151-62801912
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Funding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Awardee UEI
W2GXZM8WL2D3
Awardee CAGE
7WLR2
Performance District
MA-02
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,247,013 | 100% |
Modified: 8/5/24